|
On 20-aug-2020, abbott point of care was contacted by a customer regarding act kaolin cartridges that yielded unexpected results on a (b)(6) year old female patient during a procedure.There was no additional patient information available at the time of this report.Return product is available for investigation.Method: n/a, date: (b)(6) 2020, collected: n/a, tested: n/a, result: n/a, heparin dosage: 12,000 units, dose time: 12:11; sample: n/a, (b)(6) 2020, n/a, n/a, n/a, 1,200 units drip p/hr, i-stat, (b)(6) 2020, 16:29, 16:30, 351 sec, 2,000 units, 13:35, a; n/a, (b)(6) 2020, n/a, n/a, n/a, 1,400 units drip p/hr, i-stat, (b)(6) 2020, 17:17, 17:18, >1000 sec, 1,400 units, ni, b; i-stat, (b)(6) 2020, 17:39, 17:40, >1000sec, 1,400 units, ni, c; i-stat, (b)(6) 2020, 17:57, 17:58, 439 sec, 1,300 units drip p/hr, 18:00 , d.There are no injuries associated with this event.At this time there is no reason to suspect a malfunction exists.The reporting decision was based on the limited information available that suggests the product was not performing within the variability of the assay.The investigation is underway.
|